Pharmacologic treatment of portal hypertension in the prevention of community-acquired spontaneous bacterial peritonitis

European Journal of Gastroenterology and Hepatology

Volumn 18, Issue 1, 2006, Pages 49-55

  Gonzalez Suarez, Begoña ^a,b   Guarner, Carlos ^a   Villanueva, Candid ^a   Minana, Josep ^a   Soriano, German ^a   Gallego, Adolfo ^a   Sainz, Sergio ^a   Torras, Xavier ^a   Cusso, Xavier ^a   Balanzo, Joaquim ^a  

^a Hospital Sant Pau   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Intestinal bacterial overgrowth; Spontaneous bacterial peritonitis; Systolic blood pressure

Indexed keywords

ISOSORBIDE MONONITRATE; NADOLOL; NORFLOXACIN;

ADULT; ARTICLE; BACTERIAL INFECTION; BLEEDING; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; ENDOSCOPY; FEMALE; FOLLOW UP; HEMODYNAMIC MONITORING; HUMAN; INCIDENCE; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PERITONITIS; PORTAL HYPERTENSION; PRIORITY JOURNAL; RANDOMIZATION; SCLEROTHERAPY;

ADRENERGIC BETA-ANTAGONISTS; BACTERIAL INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; DRUG THERAPY, COMBINATION; EPIDEMIOLOGIC METHODS; ESOPHAGEAL AND GASTRIC VARICES; ESOPHAGOSCOPY; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION, PORTAL; ISOSORBIDE DINITRATE; LIGATION; MALE; MIDDLE AGED; NADOLOL; PERITONITIS; RECURRENCE; SCLEROTHERAPY; VASODILATOR AGENTS;

EID: 29344451969     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200601000-00009     Document Type: Article

References (37)

1. Guarner C, Soriano G. Spontaneous bacterial peritonitis. Semin Liver Dis 1997; 17:203-217.
2. Llovet JM, Bartoli R, March F, Planas R, Vinado B, Cabre E, et al. Translocated intestinal bacteria cause spontaneous bacterial peritonitis in cirrhotic rats: molecular epidemiologic evidence. J Hepatol 1998; 28: 307-313.
3. Runyon BA, Squier S, Borzio M. Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J Hepatol 1994; 21:792-796.
4. Guarner C, Runyon BA, Young S, Heck M, Sheikh MY. Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J Hepatol 1997; 26:1372-1378.
5. Casafont Morencos F, de las Heras Castano G, Martin Ramos L, Lopez Arias MJ, Ledesma F, Pons Romero F. Small bowel bacterial overgrowth in patients with alcoholic cirrhosis. Dig Dis Sci 1996; 41:552-556.
6. Pérez-Páramo M, Munoz J, Albillos A, Freile I, Portero F, Santos M, Ortiz-Berrocal J. Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites. Hepatology 2000; 31:43-48.
7. Pardo AB, Lorenzo-Zuñiga R, Planas V, Vinado R, Riba B, Cabre J, et al. Effect of cisapride on intestinal bacterial overgrowth and bacterial translocation in cirrhosis. Hepatology 2000; 31:858-863.
8. Abraldes JG, Tarantino I, Turnes J, Garcia-Pagan JC, Rodes J, Bosch J. Hemodynamic response to pharmacological treatment of portal hipertensión and long-term prognosis of cirrhosis. Hepatology 2003; 37:902-908.
9. Soylu AR, Dökmeci G, Tezel A, Amuca H, Ümit H. Propranolol does not affect incidence of spontaneous bacterial peritonitis in cirrhotic patients with ascites. Am J Gastroenterology 2003; 98:1446-1448.
10. Villanueva C, Balanzo J, Novella MT, Soriano G, Sainz S, Torras X, et al. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding. N Engl J Med 1996; 334:1624-1629.
11. Villanueva C, Minana J, Ortiz J, Gallego A, Soriano G, Torras X, et al. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med 2001; 345:647-655.
12. Soriano G, Guarner C, Tomas A, Villanueva C, Torras X, Gonzalez D, et al. Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal hemorrhage. Gastroenterology 1992; 103:1267-1272.
13. Guarner C, Sola R, Soriano G, Andreu M, Novella MT, Vila MC, et al. Risk of a first community-acquired spontaneous bacterial peritonitis in cirrhotics with low ascitic fluid protein levels. Gastroenterology 1999; 117:414-419.
14. Guarner C, Runyon BA. Spontaneous bacterial peritonitis: pathogenesis, diagnosis, and management. Gastroenterologist 1995; 3:311-328.
15. Ricart ES, Nnovella G, Ortiz MT, Sabat J, Kolle M, Sola-Vera L, et al. Amoxicillin-clavulanic acid versus cefotaxime in the therapy of bacterial infections in cirrhotic patients. J Hepatol 2000; 32:596-602.
16. Rimola A, Bory F, Teres J, Perez-Ayuso RM, Arroyo V, Rodes J. Oral, nonabsorbable antibiotics prevent infection in cirrhotics with gastrointestinal hemorrhage. Hepatology 1985; 5:463-467.
17. Runyon BA, Morrissey RL, Hoefs JC, Wyle FA. Opsonic activity of human ascitic fluid: a potentially important protective mechanism against spontaneous bacterial peritonitis. Hepatology 1985; 5:634-637.
18. Such J, Guarner C, Enriquez J, Rodriguez JL, Seres I, Vilardell F. Low C3 in cirrhotic ascites predisposes to spontaneous bacterial peritonitis. J Hepatol 1988; 6:80-84.
19. Tito L, Rimola A, Gines P, Llach J, Arroyo V, Rodes J. Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology 1988; 8:27-31.
20. Rimola A, Garcia-Tsao G, Navasa M, Piddock LJ, Planas R, Bernard B, Inadomi JM. Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol 2000; 32:142-153.
21. Llach J, Rimola A, Navasa M, Gines P, Salmeron JM, Gines A, et al. Incidence and predictive factors of first episode of spontaneous bacterial peritonitis in cirrhosis with ascites: relevance of ascitic fluid protein concentration. Hepatology 1992; 16:724-727.
22. Gines P, Rimola A, Planas R, Vargas V, Marco F, Almela M, et al. Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology 1990; 12:716-724.
23. Grange JD, Roulot D, Pelletier G, Pariente EA, Denis J, Ink O, et al. Norfloxacin primary prophylaxis of bacterial infections in cirrhotic patients with ascites: a double-blind randomized trial. J Hepatol 1998; 29:430-436.
24. Novella M, Sola R, Soriano G, Andreu M, Gana J, Ortiz J, et al. Continuous versus inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin. Hepatology 1997; 25:532-536.
25. Fernandez J, Navasa M, Gomez J, Colmenero J, Vila J, Arroyo V, Rodes J. Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002; 35:140-148.
26. Ortiz J, Vila MC, Soriano G, Minana J, Gana J, Mirelis B, et al. Infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients. Hepatology 1999; 29:1064-1069.
27. Sabat M, Kolle L, Soriano G, Ortiz J, Pamplona J, Novella MT, et al. Parenteral antibiotic prophylaxis of bacterial infections does not improve cost-efficacy of oral norfloxacin in cirrhotic patients with gastrointestinal bleeding. Am J Gastroenterol 1998; 93:2457-2462.
28. Gines P, Navasa M. Antibiotic prophylaxis for spontaneous bacterial peritonitis: how and whom?. J Hepatol 1998; 29:490-494.
29. Rolachon A, Cordier L, Bacq Y, Nousbaum JB, Franza A, Paris JC, et al. Ciprofloxacin and long-term prevention of spontaneous bacterial peritonitis: results of a prospective controlled trial. Hepatology 1995; 22:1171-1174.
30. Bauer TM, Follo A, Navasa M, Vila J, Planas R, Clemente G, et al. Daily norfloxacin is more effective than weekly rufloxacin in prevention of spontaneous bacterial peritonitis recurrence. Dig Dis Sci 2002; 47:1356-1361.
31. Andreu M, Sola R, SitgesSerra A, Alia C, Gallen M, Vila MC, et al. Risk factors for spontaneous bacterial peritonitis in cirrhotic patients with ascites. Gastroenterology 1993; 104:1133-1138.
32. Assi SA, Sanyal A, Schubert ML. Beta-blocker plus nitrate for primary prophylaxis of variceal bleeding. Gastroenterology 2000; 119:1170-1172.
33. Garcia-Pagan JC, Bosch J. Pharmacological prevention of variceal bleeding. New developments. Baillieres Clin Gastroenterol 1997; 11:271-287.
34. Kleber G, Ansari H, Sauerbruch T. Prophylaxis of first variceal bleeding. Baillieres Clin Gastroenterol 1992; 6:563-580.
35. Hoshino S, Shinoura S, Akamine H, Kikuchi K, Keida Y. Effect of propranolol for the prevention on spontaneous bacterial peritonitis [abstract]. Am J Gastroenterol 2000; 349:A2513.
36. Goulis J, Patch D, Burroughs AK. Bacterial infection in the pathogenesis of variceal bleeding. Lancet 1999; 353:139-142.
37. Montalto P, Vlachogiannakos J, Cox D, Pastacaldi S, Patch D, Burroughs A. Bacterial infection in cirrhosis impairs coagulation by a heparin effect: a prospective study. J Hepatol 2002; 37:463-470.